Continuous Glucose Monitoring Reveals Similar Glycemic Variability in Individuals with Obesity Despite Increased HOMA-IR

Overview

Journal Front Nutr

Specialty Nutritional Sciences

Date 2022 Dec 26

PMID 36570168

Authors

Dylan J Cooper

Sharon Zarabi

Brianna Farrand

Amanda Becker

Mitchell Roslin

Affiliations

Soon will be listed here.

Abstract

Background/aims: Continuous glucose monitoring is a well-tolerated and versatile tool for management of diabetes and metabolic disease. While its use appears to be feasible to monitor glycemic profiles in diabetics, there is a paucity of data in individuals with obesity and normal glucose tolerance. The aim of this study is to investigate glucose fluctuations and insulin resistance patterns in normoglycemic participants with obesity vs. without obesity and contextualize these results against leading models for obesity.

Materials And Methods: We designed a prospective, observational pilot study of two cohorts including 14 normoglycemic participants with obesity and 14 normoglycemic participants without obesity. Participants were monitored with continuous glucose monitoring (CGM) for five consecutive days. Insulin resistance levels were measured and glucometric data were extracted from CGM for all participants.

Results: Fasting serum insulin and homeostasis model assessment of insulin resistance (HOMA-IR) were significantly higher in the group with obesity ( < 0.05). While the group with obesity had a higher mean blood glucose (MBG), mean amplitude of glycemic excursions (MAGE), and continuous overall glycemic action-1 h (CONGA-1), these differences were not significant. On univariate linear regression, insulin resistance (HOMA-IR) was associated with body mass index (BMI), waist circumference (WC), cohort with obesity, cohort consuming a high glycemic diet, hemoglobin A1c (HbA1c), and fasting insulin levels. WC and fasting insulin levels remained predictors of HOMA-IR in our multivariable model.

Conclusion: While there is much excitement surrounding the use of commercial CGM products in obesity management, our results suggest that fasting insulin and HOMA-IR values may be more clinically useful than CGM data alone.

References

Martens T, Beck R, Bailey R, Ruedy K, Calhoun P, Peters A . Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial. JAMA. 2021; 325(22):2262-2272. PMC: 8173473. DOI: 10.1001/jama.2021.7444. View

Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette J, Diehl A . Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008; 48(6):993-9. PMC: 2423467. DOI: 10.1016/j.jhep.2008.02.011. View

Naguib M, Hegedus E, Raymond J, Goran M, Salvy S, Wee C . Continuous Glucose Monitoring in Adolescents With Obesity: Monitoring of Glucose Profiles, Glycemic Excursions, and Adherence to Time Restricted Eating Programs. Front Endocrinol (Lausanne). 2022; 13:841838. PMC: 8914373. DOI: 10.3389/fendo.2022.841838. View

Kaya A, Kocyigit C, Catli G, Ozkan E, Dundar B . The Relationship Between Glycemic Variability and Inflammatory Markers in Obese Children with Insulin Resistance and Metabolic Syndrome. J Clin Res Pediatr Endocrinol. 2017; 9(3):202-207. PMC: 5596800. DOI: 10.4274/jcrpe.4031. View

Kabir M, Rizkalla S, Champ M, Luo J, Boillot J, Bruzzo F . Dietary amylose-amylopectin starch content affects glucose and lipid metabolism in adipocytes of normal and diabetic rats. J Nutr. 1998; 128(1):35-43. DOI: 10.1093/jn/128.1.35. View

Wang Q, Zhang B, Stutz B, Liu Z, Horvath T, Yang X . Ventromedial hypothalamic OGT drives adipose tissue lipolysis and curbs obesity. Sci Adv. 2022; 8(35):eabn8092. PMC: 9432828. DOI: 10.1126/sciadv.abn8092. View

Salkind S, Huizenga R, Fonda S, Walker M, Vigersky R . Glycemic variability in nondiabetic morbidly obese persons: results of an observational study and review of the literature. J Diabetes Sci Technol. 2014; 8(5):1042-7. PMC: 4455369. DOI: 10.1177/1932296814537039. View

Mendes-Soares H, Raveh-Sadka T, Azulay S, Edens K, Ben-Shlomo Y, Cohen Y . Assessment of a Personalized Approach to Predicting Postprandial Glycemic Responses to Food Among Individuals Without Diabetes. JAMA Netw Open. 2019; 2(2):e188102. PMC: 6484621. DOI: 10.1001/jamanetworkopen.2018.8102. View

Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J . Prevalence of diabetes among men and women in China. N Engl J Med. 2010; 362(12):1090-101. DOI: 10.1056/NEJMoa0908292. View

10.

Wang Y, Beydoun M, Liang L, Caballero B, Kumanyika S . Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring). 2008; 16(10):2323-30. DOI: 10.1038/oby.2008.351. View

11.

Ludwig D, Apovian C, Aronne L, Astrup A, Cantley L, Ebbeling C . Competing paradigms of obesity pathogenesis: energy balance versus carbohydrate-insulin models. Eur J Clin Nutr. 2022; 76(9):1209-1221. PMC: 9436778. DOI: 10.1038/s41430-022-01179-2. View

12.

Rodriguez-Rodriguez R, Miralpeix C . Hypothalamic Regulation of Obesity. Int J Mol Sci. 2021; 22(24). PMC: 8704683. DOI: 10.3390/ijms222413459. View

13.

Akgun S, ERTEL N . A comparison of carbohydrate metabolism after sucrose, sorbitol, and fructose meals in normal and diabetic subjects. Diabetes Care. 1980; 3(5):582-5. DOI: 10.2337/diacare.3.5.582. View

14.

Fonda S, Graham C, Munakata J, Powers J, Price D, Vigersky R . The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes. J Diabetes Sci Technol. 2016; 10(4):898-904. PMC: 4928220. DOI: 10.1177/1932296816628547. View

15.

Rodbard D . Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. Diabetes Technol Ther. 2017; 19(S3):S25-S37. PMC: 5467105. DOI: 10.1089/dia.2017.0035. View

16.

Crapo P, Kolterman O, Olefsky J . Effects of oral fructose in normal, diabetic, and impaired glucose tolerance subjects. Diabetes Care. 1980; 3(5):575-82. DOI: 10.2337/diacare.3.5.575. View

17.

White J . Challenging the fructose hypothesis: new perspectives on fructose consumption and metabolism. Adv Nutr. 2013; 4(2):246-56. PMC: 3649105. DOI: 10.3945/an.112.003137. View

18.

Bonora B, Maran A, Ciciliot S, Avogaro A, Fadini G . Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes. J Endocrinol Invest. 2016; 39(12):1391-1399. DOI: 10.1007/s40618-016-0495-8. View

19.

Livesey G, Taylor R, Hulshof T, Howlett J . Glycemic response and health--a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes. Am J Clin Nutr. 2008; 87(1):258S-268S. DOI: 10.1093/ajcn/87.1.258S. View

20.

Srour B, Kordahi M, Bonazzi E, Deschasaux-Tanguy M, Touvier M, Chassaing B . Ultra-processed foods and human health: from epidemiological evidence to mechanistic insights. Lancet Gastroenterol Hepatol. 2022; 7(12):1128-1140. DOI: 10.1016/S2468-1253(22)00169-8. View